MedAvante Report issue

For profit Phase 2
Founded: Hackensack NJ United States (2002)
Status: Acquired by WIRB-Copernicus Group (2017)

Organization Overview

First Clinical Trial
2016
NCT03202147
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree